West Pharmaceutical Services (WST) Other Working Capital Changes (2010 - 2026)

West Pharmaceutical Services (WST) has reported Other Working Capital Changes for 16 consecutive years, with $34.6 million the latest figure, recorded in Q1 2024.

• Quarterly Other Working Capital Changes fell 26.07% year-over-year to $34.6 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was -$18.2 million (up 68.67% YoY) and the FY2025 annual result came in at -$108.1 million, down 378.32% from the prior year.
• Other Working Capital Changes climbed to $34.6 million in Q1 2024 per WST's latest filing, from -$53.3 million in the prior quarter.
• Over the last five years, Other Working Capital Changes for WST reached as high as $102.9 million in Q1 2026 and fell as low as -$26.0 million in Q4 2023.
• A 4-year average of $11.2 million and a median of -$1.1 million in 2025 frame the typical range for Other Working Capital Changes.
• The largest YoY upside for Other Working Capital Changes was 5600.0% in 2020 against a maximum downside of 8240.0% in 2020.
• Year by year, Other Working Capital Changes stood at -$77.4 million in 2020, then surged by 74.29% to -$19.9 million in 2021, then tumbled by 831.66% to -$185.4 million in 2022, then soared by 71.25% to -$53.3 million in 2023, then jumped by 164.92% to $34.6 million in 2024.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered $34.6 million, -$53.3 million, and -$24.8 million for Q1 2024, Q4 2023, and Q3 2023 respectively.